Market News
Latest news from Stock markets.
Shell: Continued Investment And Incredibly Strong FCF
Shell plc delivers double-digit FCF yields, combining a nearly 4% dividend and 6% annualized buybacks, even amid a weak pricing environment and $20B+ annual capex. SHEL's portfolio strength is anchored in integrated oil and gas; renewables remain immaterial, posing a long-term risk as energy markets evolve. Significant new high-margin international projects and LNG capacity coming online through 2027 support sustained double-digit FCF/share growth in SHEL stock.
...keep reeding on seekingalpha.com
ASA: Ditch Physical Gold And Buy The Miners
ASA Gold and Precious Metals Limited offers discounted exposure to gold and precious metals miners, trading at a -10% NAV discount. ASA's portfolio emphasizes smaller-cap gold producers, with 61.3% of NAV in companies under $2 billion and 85% domiciled in Canada. Miners in ASA's portfolio can leverage high gold prices for operating cash flow, even if gold prices stabilize around $4,200/oz.
...keep reeding on seekingalpha.com
NOBLE CORPORATION PLC ANNOUNCES PLANNED DIVESTMENT OF SIX JACKUPS
HOUSTON , Dec. 8, 2025 /PRNewswire/ -- Noble Corporation plc (NYSE: NE, "Noble" or the "Company") today announced that the Company has signed definitive agreements to sell six jackups, which includes the sale of five rigs to Borr Drilling Limited (NYSE: BORR, "Borr") for $360 million and a separate transaction for the sale of one rig to Ocean Oilfield Drilling for $64 million in cash. Upon closing of these transactions, which are subject to satisfaction of customary closing conditions, Noble will be a pureplay deepwater and ultra-harsh environment jackup operator.
...keep reeding on prnewswire.com
AeroVironment Awarded $874M Foreign Military Sales IDIQ to Deliver UAS and C-UAS Systems to Allied & Partner Forces
ARLINGTON, Va.--(BUSINESS WIRE)---- $AVAV--AeroVironment (AV) (NASDAQ: AVAV), a global leader in all-domain autonomous systems, has been awarded a five-year Indefinite Delivery, Indefinite Quantity (IDIQ) contract worth $874.26 million from the U.S. Army Contracting Command. This contract will support future foreign military sales (FMS) through the Program Executive Office (PEO) Aviation, enabling allied and partner forces to procure a range of Groups 1-3 unmanned aerial systems (UAS) and counter-UAS (C-.
...keep reeding on businesswire.com
Macy's CEO closely studies Costco, Abercrombie and Apple
Macy's CEO Tony Spring says that he closely follows brands like Abercrombie, Apple and Costco for business inspiration, because each brand has a unique experience that sets it apart.
...keep reeding on youtube.com
Trump greenlights Nvidia H200 AI chip sales to China, says Xi responded positively
Trump greenlights Nvidia H200 AI chip sales to China, says Xi responded positively
...keep reeding on cnbc.com
Whoever Replaces Tim Cook at Apple Will Have 'Big Shoes to Fill'
Tim Cook ushered Apple into the age of smartwatches and wireless headphones. Will he be around for its AI era?
...keep reeding on investopedia.com
This Energy Provider Is the Latest to Score Big AI Data Center Deals
NextEra Energy is raking in new deals to power AI data centers.
...keep reeding on investopedia.com
Carrier Connect Data Solutions Inc. Announces Option Grant
Vancouver, British Columbia, December 8, 2025 – TheNewswire - Carrier Connect Data Solutions Inc. (TSX.V:CCDS; OTCQB:CCDSF; WKN : A40XB1 ) (the “ Company ”), a data center company on a mission to roll up Tier II/III data centers internationally that specialize in delivering co-location, announces that it has granted 460,000 incentive stock options (the “ Options ”) to certain directors, officers, employees and consultants of the Company in accordance with its stock option plan. Such Options are exercisable at a price of $0.98 until December 8, 2035 of which (depending on the recipient), 315,000 vest immediately, 36,250 vest at six months following the date of grant, 36,250 vest at twelve months following the date of grant, 36,250 vest at eighteen months following the date of grant, and 36,250 v est at twenty four months following the date of grant, all subject to applicable hold periods. About Carrier Connect Data Solutions Inc.
...keep reeding on thenewswire.com
Red Rock Resorts: Moving Higher Against Headwinds
Red Rock Resorts' savvy unveils upscale property in Durango aimed at Vegas locals. More than $1 billion to build and expand local property is a huge risk. Early results are impressive, validating the risk in a bad macro environment.
...keep reeding on seekingalpha.com
SoftBank and Nvidia Consider Joining Funding Round for Robotics Firm Skild AI
SoftBank Group and Nvidia are reportedly in talks to participate in a more than $1 billion funding round for Skild AI, a maker of foundation models for robots. The round, which has not been finalized and could change, could nearly triple Skild's valuation from the $4.
...keep reeding on pymnts.com
Netflix, Paramount fight for Warner Bros Discovery in Hollywood power tussle
Paramount Skydance launched a hostile bid worth $108.4 billion for Warner Bros Discovery , challenging a rival offer from Netflix and injecting uncertainty into the future of Hollywood's storied media company.
...keep reeding on reuters.com
US to allow Nvidia to ship H200 chips to China, Trump says
U.S. President Donald Trump said on Monday that he will allow Nvidia to ship its H200 chips to approved customers in China and other Countries, under conditions that allow for continued strong national security.
...keep reeding on reuters.com
Appia Rare Earths & Uranium Corp. Issues Reminder for December 9, 2025 Presentation at the "John Tumazos Very Independent Research Conference"
Toronto, Ontario--(Newsfile Corp. - December 8, 2025) - Appia Rare Earths & Uranium Corp. (CSE: API) (OTCQB: APAAF) (FWB: A0I0) (MUN: A0I0) (BER: A0I0) (the "Company" or "Appia") is pleased to issue a reminder that it will be presenting at the "John Tumazos Very Independent Research Virtual Conference" on Tuesday, December 9, 2025 at 9:45 AM EST. Appia's presentation will provide a concise update on its ongoing exploration activities, including: Progress at the PCH Ionic Adsorption Clay and Carbonatitic Mineralization Property in Brazil (a USD $6 million exploration program fully funded by Ultra Rare Earth Inc.) 2026 exploration programs for the Alces Lake Rare Earth Element and Otherside Uranium Properties in Saskatchewan Recent developments at the Elliot Lake Uranium and Rare Earths Project in Ontario.
...keep reeding on newsfilecorp.com
Department of Commerce may approve Nvidia H200 chip exports to China
Advanced Nvidia AI chips may be headed to China after all.
...keep reeding on techcrunch.com
AMD CEO: AI is “nowhere near its peak capability”
AMD CEO Lisa Su tells Wall Street Week's David Westin that AI is not a fad, it has extreme potential, but "it's nowhere near its peak capability." Tune into this interview this Friday on Wall Street Week at 6pm ET: https://bloom.bg/3KK32su
...keep reeding on youtube.com
Overlooked Stock: SATS Hits All-Time High
EchoStar (SATS) rallied nearly 300% since the start of 2025. George Tsilis attributes much of that rally to SpaceX and its equity connection to the Elon Musk's private company.
...keep reeding on youtube.com
Putin clears deals with Rosneft and Shell's joint-venture stake in Caspian Pipeline Consortium
Russian President Vladimir Putin issued a decree on Monday clearing potential deals with Rosneft and Shell's joint-venture stake in the Caspian Pipeline Consortium, which exports oil mainly from Kazakhstan.
...keep reeding on reuters.com
CFLT stock price: IBM deal to buy Confluent for $11 billion shows investors still think AI is popping
IBM announced on Monday it is acquiring Confluent for $11 billion, sending shares of the data streaming platform up about 29% in morning trading.
...keep reeding on fastcompany.com
Asseco Poland S.A. (ASOZY) Q3 2025 Earnings Call Transcript
Asseco Poland S.A. (ASOZY) Q3 2025 Earnings Call Transcript
...keep reeding on seekingalpha.com
Recursion Pharmaceuticals, Inc. (RXRX) Discusses Updated Safety and Efficacy Data from TUPELO Phase I/II Study of REC-4881 in FAP Transcript
Recursion Pharmaceuticals, Inc. (RXRX) Discusses Updated Safety and Efficacy Data from TUPELO Phase I/II Study of REC-4881 in FAP Transcript
...keep reeding on seekingalpha.com
Rockland Resources Arranges Financing
Vancouver, British Columbia, December 8, 2025 – TheNewswire – Rockland Resources Ltd. (the “Company” or "Rockland") ( CSE: RKL ) (OTCQB: BERLF) (FSE: GB2) announces that it has arranged a non-brokered private placement of 7.5 million units ("Units") at a price of $0.08 per Unit for aggregate gross proceeds of $600,000.00 (the "Offering"). Each Unit will be comprised of one common share ("Share") and one transferable Share purchase warrant of the Company ("Warrant"). Each Warrant will entitle the Subscriber to purchase one Warrant Share for a 48-month period after the Closing Date at an exercise price of $0.12 per share. Net proceeds of the Financing will be used to advance the Corporation's Cole Gold Mines project in Red Lake, Ontario and for general working capital purposes . Shares issued pursuant to the Financing will be subject to a four-month hold period according to applicable securities laws of Canada.
...keep reeding on thenewswire.com
DWS Municipal Income Trust Declares Monthly Distribution
NEW YORK--(BUSINESS WIRE)--DWS Municipal Income Trust (KTF) (the “Fund”) announced today its regular December monthly distribution. Details are as follows: Declaration – 12/08/2025 Ex-Date – 12/19/2025 Record – 12/19/2025 Payable – 12/30/2025 Fund Ticker Distribution Per Share Prior Distribution Per Share DWS Municipal Income Trust KTF $0.0610 $0.0610 The Fund intends to distribute all or substantially all of its net investment income each year through its regular monthly distributions.
...keep reeding on businesswire.com
Alexandria Real Estate Equities, Inc. Stockholders Can Lead the Securities Class Action - ARE Investors Should Contact Robbins LLP Today
SAN DIEGO , Dec. 8, 2025 /PRNewswire/ -- Company: Alexandria Real Estate Equities, Inc. (NYSE: ARE) is a real estate investment trust (REIT) specializing in lifescience real estate with a focus on lab space, research facilities and offices for tenants in the pharmaceutical, biotech, and agricultural technology industries. What is the class period?
...keep reeding on prnewswire.com
Aeroméxico November 2025 Traffic Results
MEXICO CITY, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Grupo Aeroméxico S.A.B. de C.V. (NYSE: AERO & BMV: AERO) (“Aeroméxico”) reports its November 2025 operational results:
...keep reeding on globenewswire.com
Incyte Presents Updated Positive Data at ASH 2025 Reinforcing the Potential of INCA033989, its First-in-Class mutCALR-Targeted Monoclonal Antibody, in Patients with Essential Thrombocythemia
WILMINGTON, Del.--(BUSINESS WIRE)---- $INCY #ASH2025--Updated Positive Data at ASH 2025 Reinforce the Potential of Incyte's INCA033989, its First-in-Class mutCALR-Targeted Monoclonal Antibody, in ET.
...keep reeding on businesswire.com
ASUR Announces Total Passenger Traffic for November 2025
Passenger traffic increased year-over-year by 5.9% in Colombia and 1.0% in Mexico and decreased by 2.9% in Puerto Rico. MEXICO CITY , Dec. 8, 2025 /PRNewswire/ -- Grupo Aeroportuario del Sureste, S.A.B.
...keep reeding on prnewswire.com
John Stankey to Update Shareholders at UBS Global Media & Communications Conference on Dec. 9
DALLAS , Dec. 8, 2025 /PRNewswire/ -- Tomorrow, AT&T's Chairman and Chief Executive Officer will participate in a fireside chat at 8:15 a.m. ET to discuss the Company's progress on its multi-year growth strategy Key Takeaways: AT&T reiterates all full-year 2025 and multi-year financial guidance and capital return plans provided with its third-quarter 2025 earnings report, including $4 billion of share repurchases in 2025 and an expected $20 billion of share repurchase capacity during 2025-2027 AT&T continues to win 5G and fiber customers through solid execution on its multi-year growth plan centered on putting customers first AT&T expects to close its transactions with Lumen and EchoStar in early 2026 John Stankey, Chairman and Chief Executive Officer, AT&T (NYSE:T), will speak tomorrow at the UBS Global Media & Communications Conference where he will provide an update to shareholders.
...keep reeding on prnewswire.com
Bristol Myers Squibb Advances Lymphoma Research with New Targeted Protein Degradation and Cell Therapy Data at ASH 2025
PRINCETON, N.J.--(BUSINESS WIRE)---- $BMY #ASH--Bristol Myers Squibb Advances Lymphoma Research with New Targeted Protein Degradation and Cell Therapy Data at ASH 2025.
...keep reeding on businesswire.com
PepsiCo Announces Priorities to Enhance Shareholder Value and Provides Preliminary 2026 Financial Outlook
Highlights suite of innovation, productivity and affordability initiatives at PepsiCo Foods North America to accelerate growth and improve core 1 operating margin performance Expects organic revenue, core constant currency and core earnings per share (EPS) growth to accelerate in fiscal 2026 with strong core operating margin expansion Prioritizes disciplined capital allocation framework, improving free cash flow conversion and increasing cash returns to shareholders Aims to optimize North American supply chain and go-to-market systems Follows constructive engagement with supportive PepsiCo shareholder Elliott Investment Management Live Q&A session at 7:30AM EST on Tuesday, December 9, 2025, with PepsiCo Chairman and CEO PURCHASE, N.Y. , Dec. 8, 2025 /PRNewswire/ -- PepsiCo, Inc. (NASDAQ: PEP ) today announced certain commercial and financial priorities to enhance shareholder value, including a preliminary 2026 financial outlook.
...keep reeding on prnewswire.com
Quaker Houghton Recognized on Newsweek's List of America's Most Responsible Companies
CONSHOHOCKEN, Pa. , Dec. 8, 2025 /PRNewswire/ -- Quaker Houghton (NYSE: KWR), the global leader in industrial process fluids, has been named one of America's Most Responsible Companies for a third consecutive year.
...keep reeding on prnewswire.com
StubHub Holdings, Inc. Stockholders can Lead the Securities Class Action - STUB Investors Should Contact Robbins LLP Today
SAN DIEGO , Dec. 8, 2025 /PRNewswire/ -- Company: StubHub Holdings, Inc. (NYSE: STUB) operates a global ticketing marketplace for live events where fans can buy tickets from sellers of all types through the Company's StubHub and viagogo websites and mobile applications. What is the class period?
...keep reeding on prnewswire.com
AAR extends commercial distribution agreement with Arkwin Industries
WOOD DALE, Ill. , Dec. 8, 2025 /PRNewswire/ -- AAR CORP.
...keep reeding on prnewswire.com
Hungry Hippo Fairing Successfully Qualified: Rocket Lab Clears Significant Milestone on Path to First Neutron Launch
Rocket Lab announces that the Neutron rocket's innovative “Hungry Hippo” fairing has successfully completed qualification testing and is enroute to LC-3.
...keep reeding on globenewswire.com
Toll Brothers Reports FY 2025 Fourth Quarter Results
FORT WASHINGTON, Pa., Dec. 08, 2025 (GLOBE NEWSWIRE) -- Toll Brothers, Inc. (NYSE:TOL) (TollBrothers.com), the nation's leading builder of luxury homes, today announced results for its fourth quarter ended October 31, 2025.
...keep reeding on globenewswire.com
FG Nexus Further Enhances Governance and Appoints Scott D. Wollney as Lead Independent Director
Charlotte, NC, Dec. 08, 2025 (GLOBE NEWSWIRE) -- FG Nexus Inc. (Nasdaq: FGNX, FGNXP) (the “Company”), today announced the appointment of Scott D. Wollney as Lead Independent Director of the Company's Board of Directors. Mr. Wollney has served as a director of the Company for the past 10 years, and currently chairs the Audit Committee and is a member of the Compensation & Management Resources Committee.
...keep reeding on globenewswire.com
Genmab Announces New Data from Phase 1b/2 EPCORE® CLL-1 Highlighting Potential of Epcoritamab as Monotherapy and in Combination for Patients with Richter Transformation (RT)
Media Release COPENHAGEN, Denmark; December 8, 2025 Two-year epcoritamab monotherapy data demonstrate high complete response and encouraging survival rates in patients with Richter transformation (RT), highlighting its potential as a treatment option for those unsuitable for chemotherapy Additional early data show promising efficacy of epcoritamab combination regimens in patients with RT Results underscore the potential of epcoritamab as a versatile therapy for a broad range of B-cell malignancies Genmab A/S (Nasdaq: GMAB ) today announced new and updated data from t hree arms of the ongoing Phase 1 b/2 EPCORE ® CLL-1 trial ( NCT04623541 ) evaluating the efficacy and safety of epcoritamab-bysp, a T-cell engaging bispecific antibody administered subcutaneously , as a monotherapy and in combination for the treatment of patients with Richter transformation (R T), a rare complication in which chronic lymphocytic leukemia (CLL) evolves into an aggressive lymphoma, most often diffuse large B-cell lymphoma (DLBCL). The results were presented today in two oral presentations (abstracts 1015 and 1017) at the 67th Annual Meeting and Exposition of the American Society of Hematology (ASH), in Orlando, Florida.
...keep reeding on globenewswire.com
Roche presents Lunsumio data showing potential across earlier treatment lines in indolent and aggressive lymphomas
Basel, 8 December 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today new data highlighting the potential of Lunsumio® (mosunetuzumab) in earlier treatment lines for people living with different types of lymphoma, presented at the 67th American Society of Hematology Annual Meeting and Exposition, 6-9 December 2025 in Orlando, Florida, US.
...keep reeding on globenewswire.com
Exicure Presents Positive Topline Phase 2 Data for Burixafor in Multiple Myeloma at 2025 ASH Annual Meeting
REDWOOD CITY, Calif., Dec. 08, 2025 (GLOBE NEWSWIRE) -- Exicure, Inc. (Nasdaq: XCUR), a clinical-stage biotechnology company developing therapeutics for hematologic diseases, today announced positive results from its completed Phase 2 trial evaluating burixafor (GPC-100) in combination with propranolol and granulocyte colony-stimulating factor (G-CSF) for the mobilization of hematopoietic progenitor cells (HPCs) in patients with multiple myeloma undergoing autologous hematopoietic cell transplantation (AHCT). The data, which showed that approximately 90% of study participants achieved the primary endpoint, were presented today in an oral session at the 67th American Society of Hematology (ASH) Annual Meeting in Orlando, Florida.
...keep reeding on globenewswire.com
United Community Banks, Inc. Announces Extension of Share Repurchase Program
GREENVILLE, S.C., Dec. 08, 2025 (GLOBE NEWSWIRE) -- United Community Banks, Inc. (NYSE: UCB) (the “Company”) today announced that the Company's Board of Directors approved a common stock repurchase program, authorizing the repurchase of up to $100.0 million of its outstanding common stock on the open market, in privately negotiated transactions, or in any other manner that complies with the provisions of the Securities Exchange Act of 1934, as amended (the “Stock Repurchase Program”). The Company may make repurchases under the Stock Repurchase Program from time to time beginning after the expiration of its current common stock repurchase program on December 31, 2025, and ending on December 31, 2026. The Company has repurchased $44 million of shares in 2025 under its current common stock repurchase program.
...keep reeding on globenewswire.com
Genentech Presents Lunsumio Data Showing Potential Across Earlier Treatment Lines in Indolent and Aggressive Lymphomas
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today new data highlighting the potential of Lunsumio® (mosunetuzumab-axgb) in earlier treatment lines for people living with different types of lymphoma, presented at the 67th American Society of Hematology Annual Meeting and Exposition, December 6-9, 2025 in Orlando, Florida. “These data underscore the potential of Lunsumio to support more people living with lymphoma, b.
...keep reeding on businesswire.com
Tornado Infrastructure Equipment Announces Completion of Plan of Arrangement with the Toro Company
CALGARY, AB / ACCESS Newswire / December 8, 2025 / Tornado Infrastructure Equipment Ltd. ("Tornado" or the "Company") (TSX-V:TGH)(OTCQX:TGHLF) is pleased to announce the completion of the previously announced plan of arrangement (the "Arrangement") involving the Company, The Toro Company ("Toro") and Tornado Acquisition Company ULC (the "Purchaser"), an affiliate of Toro, pursuant to which the Purchaser acquired all of the issued and outstanding Class "A" common shares (the "Shares") of the Company for cash consideration of $1.92 per Share.
...keep reeding on accessnewswire.com
Pershing Square Holdings, Ltd. Releases Date of Annual London Investor Presentation
LONDON--(BUSINESS WIRE)--Pershing Square Holdings, Ltd. (LN:PSH) (LN:PSHD) today announced that it will hold its annual PSH Investor Presentation on 11 February 2026 at 15:00 GMT (10:00 EST). Any person wishing to attend must be an existing PSH shareholder or bondholder at the time of the presentation. A livestream of the event will also be available. Additional eligibility and registration details are available at www.pershingsquareholdings.com. About Pershing Square Holdings, Ltd. Pershing Sq.
...keep reeding on businesswire.com
The Toro Company Completes Acquisition of Tornado Infrastructure Equipment Ltd.
BLOOMINGTON, Minn.--(BUSINESS WIRE)--The Toro Company successfully completes its acquisition of publicly held Tornado Infrastructure Equipment Ltd.
...keep reeding on businesswire.com
Genmab Announces New Data from Phase 1b/2 EPCORE® CLL-1 Highlighting Potential of Epcoritamab as Monotherapy and in Combination for Patients with Richter Transformation (RT)
COPENHAGEN, Denmark--(BUSINESS WIRE)--Genmab A/S (Nasdaq: GMAB) today announced new and updated data from three arms of the ongoing Phase 1b/2 EPCORE® CLL-1 trial (NCT04623541) evaluating the efficacy and safety of epcoritamab-bysp, a T-cell engaging bispecific antibody administered subcutaneously, as a monotherapy and in combination for the treatment of patients with Richter transformation (RT), a rare complication in which chronic lymphocytic leukemia (CLL) evolves into an aggressive lymphoma.
...keep reeding on businesswire.com
Advance Auto Parts Announces Leadership Transition; Appoints Ronald Gilbert as Senior Vice President of Supply Chain
RALEIGH, N.C.--(BUSINESS WIRE)--Advance Auto Parts, Inc. (NYSE: AAP), a leading automotive aftermarket parts provider in North America that serves both professional installers and do-it-yourself customers, announced today that it has appointed Ronald Gilbert as senior vice president of supply chain, effective December 22, 2025. Mr. Gilbert will report directly to president and chief executive officer, Shane O'Kelly. Mr. Gilbert will be responsible for all aspects of the Company's supply chain o.
...keep reeding on businesswire.com
The Hackett Group, Inc. Announces Final Results of Its $40 Million Dutch Auction Tender Offer
MIAMI--(BUSINESS WIRE)--The Hackett Group, Inc. Announces Final Results of Its $40 Million Dutch Auction Tender Offer.
...keep reeding on businesswire.com
Butterfield Announces New Share Repurchase Program for 2026
HAMILTON, Bermuda--(BUSINESS WIRE)--The Bank of N.T. Butterfield & Son Limited ("Butterfield" or the "Bank") (BSX: NTB.BH; NYSE: NTB) today announced that its Board of Directors has approved a $140 million ordinary share repurchase program (“the Share Repurchase Program”) pursuant to which the Bank is authorized to purchase up to 3.0 million of its ordinary shares through December 31, 2026. Michael Collins, Chairman and Chief Executive Officer said: “I am pleased to announce Butterfield's n.
...keep reeding on businesswire.com
Cogent Biosciences, Inc. (COGT) Discusses Full SUMMIT and Positive APEX Trial Results in Systemic Mastocytosis at ASH Conference Transcript
Cogent Biosciences, Inc. (COGT) Discusses Full SUMMIT and Positive APEX Trial Results in Systemic Mastocytosis at ASH Conference Transcript
...keep reeding on seekingalpha.com
Vornado Declares Common Dividend of $.74 Per Share
NEW YORK, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Vornado Realty Trust (NYSE:VNO) announced today that its Board of Trustees has declared a dividend of $.74 per common share. The dividend will be payable on December 29, 2025 to shareholders of record on December 18, 2025.
...keep reeding on globenewswire.com
Johnson & Johnson to Participate in the 44th Annual J.P. Morgan Healthcare Conference
NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) will present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12th, 2026. Management will participate in a Fireside Chat at 11:15 a.m. Eastern Time. A live audio webcast of the presentation will be accessible through Johnson & Johnson's Investor Relations website at www.investor.jnj.com. An archived edition of the session will be available later that day. The audio webcast replay will be available.
...keep reeding on businesswire.com